Skip to main content
Signal8

GRAY WILLIAM GARRETT

SEC insider (Form 3/4/5 filer). CIK 0001692961. Chief Financial Officer at Checkpoint Therapeutics, Inc. (CKPT). 6 reported Form 4/5 transactions since Sep 2024; latest on May 30, 2025. Located in WALTHAM, MA.

Companies GRAY WILLIAM GARRETT has filed insider reports for

  • Checkpoint Therapeutics, Inc. (CKPT): Officer, Chief Financial Officer
GRAY WILLIAM GARRETT profile photo

GRAY WILLIAM GARRETT

CIK: 0001692961

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Checkpoint Therapeutics, Inc. logo
CKPT

Checkpoint Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Checkpoint Therapeutics, Inc. logo
    CKPT

    Checkpoint Therapeutics, Inc.

    May 30, 2025
    Tender Offer
    Direct
    1.4M shares-
  • Checkpoint Therapeutics, Inc. logo
    CKPT

    Checkpoint Therapeutics, Inc.

    Apr 1, 2025
    Sale
    Direct
    12.3K shares at avg. $4.05$50K
  • Checkpoint Therapeutics, Inc. logo
    CKPT

    Checkpoint Therapeutics, Inc.

    Feb 6, 2025
    Sale
    Direct
    74.1K shares at avg. $3.67$272K
  • Checkpoint Therapeutics, Inc. logo
    CKPT

    Checkpoint Therapeutics, Inc.

    Jan 30, 2025
    Award
    Direct
    500K shares-
  • Checkpoint Therapeutics, Inc. logo
    CKPT

    Checkpoint Therapeutics, Inc.

    Dec 18, 2024
    Sale
    Direct
    268.4K shares at avg. $4.01$1.1M
  • Checkpoint Therapeutics, Inc. logo
    CKPT

    Checkpoint Therapeutics, Inc.

    Dec 13, 2024
    Award
    Direct
    629K shares-

1-6 of 6